Menu
Montecito
Pac Premier
Giving Guide
Loading...
You are here:  Home  >  Latest news  -  Page 698
Latest

Environmentalists sue regulators for not releasing info on tri-county oil pipelines

By   /  Tuesday, December 8th, 2015  /  Energy, Latest news, Law, Top Stories  /  Comments Off on Environmentalists sue regulators for not releasing info on tri-county oil pipelines

  Environmental groups have filed lawsuits against federal regulators for allegedly refusing to release information regarding oil pipelines in the Tri-Counties. The Environmental Defense Center and Santa Barbara Channelkeepers sent a Freedom of Information Act request to the Pipeline and Hazardous Materials Safety Administration on May 22. PHMSA has yet to fulfill the FOIA requests, Read More →

Read More →
Latest

Amgen Tour of California to stage April preview ride in tri-counties

By   /  Tuesday, December 8th, 2015  /  Latest news  /  Comments Off on Amgen Tour of California to stage April preview ride in tri-counties

Tri-county cyclists will have the chance to ride like the pros and with them on April 24. Organizers of the Amgen Tour of California professional bike race said Dec. 8 that an April 24 preview ride will take place along the Stage 3 route for the 2016 Tour of California. During the preview ride, fans Read More →

Read More →
Latest

CPUC approves Frontier takeover of Verizon subscribers

By   /  Monday, December 7th, 2015  /  Latest news  /  Comments Off on CPUC approves Frontier takeover of Verizon subscribers

The California Public Utilities Commission approved on Dec. 4 Frontier Communications’ application to buy all Internet, TV and landline phone subscribers in California from Verizon Communications. Norwalk, Conn.-based Frontier agreed in February to pay Verizon $10.5 billion for all Internet, TV and phone subscribers in California, Texas and Florida. The Federal Communications Commission approved the Read More →

Read More →
Latest

Novartis biosimilar works as well as Amgen’s Neulasta

By   /  Monday, December 7th, 2015  /  Central Coast Health Watch, Latest news, Tri-County Public Companies  /  Comments Off on Novartis biosimilar works as well as Amgen’s Neulasta

Swiss pharmaceutical Novartis announced Monday that a copycat version of Amgen’s Neulasta works just as well to prevent a condition that can lead to infection in women with breast cancer. Neulasta stimulates white blood cell production in the body, which helps the body fight cancer. Novartis’ new drug is part of a new class of Read More →

Read More →
Latest

Amgen seeks European OK of biosimilar drug, partners with Merck on studies

By   /  Friday, December 4th, 2015  /  Central Coast Health Watch, East Ventura County, Latest news, Tri-County Public Companies  /  Comments Off on Amgen seeks European OK of biosimilar drug, partners with Merck on studies

Amgen announced two developments Dec. 4 that should help the Thousand Oaks-based biotech giant compete. Amgen said it is seeking approval from the European Medicines Agency for ABP 501, a biosimilar drug similar to Humira. Amgen also announced a partnership with New Jersey-based pharmaceutical Merck to partner in a non-Hodgkins lymphoma study using drugs from Read More →

Read More →
Latest

Amgen bipolar about biosimilars

By   /  Friday, December 4th, 2015  /  Central Coast Health Watch, Latest news, Top Stories, Tri-County Public Companies  /  Comments Off on Amgen bipolar about biosimilars

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Ventura hillside development moves forward despite opposition

By   /  Friday, December 4th, 2015  /  Latest news, Real Estate, Top Stories, West Ventura County  /  Comments Off on Ventura hillside development moves forward despite opposition

"Save Our Hillside" signs line the neighborhood on Hillcrest Drive, situated just below the proposed development.

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →